Results 221 to 230 of about 820,695 (332)

Neuromodulation for Drug-Resistant Chronic Cluster Headache: Efficacy and Safety in a Series of Four Cases

open access: diamond
Facundo Villamil   +4 more
openalex   +2 more sources

FELASA Congress 2025

open access: yesAnimal Models and Experimental Medicine, EarlyView.
Themed “Reducing Severity in Animal Research,” FELASA 2025 Congress attracted experts and scholars from the global laboratory animal sciences field. Abstract The FELASA 2025 Congress, themed “Reducing Severity in Animal Research,” convened global experts in laboratory animal sciences to discuss ethical advancements, welfare standards, and innovative ...
Lai Wei
wiley   +1 more source

The HIT-6 Questionnaire Corresponds to the PedMIDAS for Assessment of Pediatric Headaches. [PDF]

open access: yesHealthcare (Basel)
Genizi J   +6 more
europepmc   +1 more source

Disease Progression in Multiple System Atrophy: The ASPIRE Multi‐Modal Biomarker Study

open access: yesAnnals of Neurology, EarlyView.
Objective The objective of this study was to characterize changes in candidate biomarkers in early multiple system atrophy (MSA) and identify baseline predictors of faster progression. Methods This 1‐year, multicenter, prospective study assessed clinical, neuroimaging (3T‐magnetic resonance imaging [MRI], dopamine transporter single‐photon emission ...
Margherita Fabbri   +26 more
wiley   +1 more source

Trametinib in Adults with Neurofibromatosis Type 1‐Related Symptomatic Plexiform Neurofibromas

open access: yesAnnals of Neurology, EarlyView.
Objective Mitogen‐activated protein kinase kinase inhibitors have shown promising results in treatment of plexiform neurofibromas in neurofibromatosis type 1 patients, but data in adults are limited. The aim of this phase 2 study was to investigate the efficacy and safety of trametinib in adults with neurofibromatosis type 1.
D. Christine Noordhoek   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy